Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03944278 · ClinicalTrials.gov registry record · NA
Pilot Evaluation of Thulium Laser Alone or in Combination With Broad Band Light for Treatment of Dermatologic Conditions
A NA study, sponsored by Sciton.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03944278 is a NA study that has completed, run by Sciton. The registered enrollment target is 15 participants.
The verdict
NCT03944278, a NA study, has completed, sponsored by Sciton.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Evaluate the Thulium laser device for skin resurfacing procedures, or as a treatment for pigmented lesions (age or sun spots) or dyschromia; or cutaneous lesions such as, but not limited to, actinic keratosis, melasma, fine rhytides; or as a method of improving skin tone and skin texture
Interventions
- DEVICE Thulium Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-04-12 |
| Est. Completion | 2020-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03944278
The ClinicalTrials.gov registry entry for NCT03944278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sciton, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thulium Laser is the first listed.
NCT03944278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03944278 about?
NCT03944278 is a clinical study titled "Pilot Evaluation of Thulium Laser Alone or in Combination With Broad Band Light for Treatment of Dermatologic Conditions". Evaluate the Thulium laser device for skin resurfacing procedures, or as a treatment for pigmented lesions (age or sun spots) or dyschromia; or cutaneous lesions such as, but not limited to, actinic keratosis, melasma, fine rhytides; or as a method of improving skin tone and skin texture
What is the current status of trial NCT03944278?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-04-12. Estimated completion is 2020-09-29.
What interventions are being tested in trial NCT03944278?
The interventions under investigation include: Thulium Laser (DEVICE).
Who is sponsoring clinical trial NCT03944278?
This trial is sponsored by Sciton, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.